---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-034006"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2024-08-27T23:59:59+00:00"
generated_at: "2026-05-31T07:29:43.524723+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics reports $3.9M gross proceeds from GEM equity line draw downs

## Summary
- On Aug 26, 2024, sold 100,000 shares at net $4.51 (10% discount), gross $451K.
- Prior draw down: 840,000 shares at net $4.09, gross $3,436K; 560,000 shares returned for cancellation.
- Aggregate gross proceeds from GEM SPA subsequent to June 30, 2024: $3,887K.
- Remaining 1,500,000 shares from July 12 draw down returned to Company and cancelled.

## SEC filing metadata
- accession: 0001493152-24-034006
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2024-08-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000149315224034006/0001493152-24-034006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000149315224034006/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-034006
- JSON: https://secwatch.observer/filing/0001493152-24-034006.json
- Plain text: https://secwatch.observer/filing/0001493152-24-034006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.